AxoGen elects Kevin Leach as VP of Marketing.
M2 EQUITYBITES-March 14, 2016-AxoGen elects Kevin Leach as VP of Marketing
(C)2016 M2 COMMUNICATIONS http://www.m2.com
Surgical solutions company AxoGen (NasdaqCM:AXGN) revealed on Monday that it has appointed Kevin Leach as vice president of Marketing
Effective immediately, Leach is responsible for the company's global marketing strategies and functions, reporting directly to president and CEO and Karen Zaderej.
Most recently, Leach has served as the vice president, Global Knee Marketing of Stryker Corporation, a medical technology company.
Leach previously worked as vice president, Americas, Wound Therapeutics & Critical Care as well as global marketing leader for ConvaTec, a Bristol-Myers Squibb company, where he led the launch of new products globally.
In the past, Leach was part of Zimmer UK, a medical device company, where he headed a newly established division for the Orthopaedic business unit focusing on market development and commercialisation of an injectable Hyaluronic Acid for the relief of joint pain.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Publication:||M2 EquityBites (EQB)|
|Date:||Mar 14, 2016|
|Previous Article:||International Wire declares reduced net income for Q4 2015 year over year.|
|Next Article:||STRATA Skin Sciences posts lower Q4 2015 net loss of USD0.6m.|